A webinar series offered by the American Psychiatric Association as part of the CSAT-Funded Physicians Clinical Support System-Buprenorphine (PCSS-B).
Click here for more information.
Register at https://www2.gotomeeting.com/register/860211762>
This webinar on January 11, 2011 will be presented by Herbert Kleber, M.D., Professor of Psychiatry for Columbia University and Director of the Division of Substance Abuse for the New York State Psychiatric
Institute. Maintenance vs. Detoxification and Short Term vs. Long Term Maintenance are debates that have gone on for over 100 years. These concerns had been of more interest recently with the introduction of buprenorphine for
office-based practice and the entry of many new clinicians into the opioid addiction treatment field. The growing number of buprenorphine patients, including younger individuals with
relatively short histories of opioid abuse, present new challenges for the clinician. One major problem is the relative lack of scientific data on the efficacy of maintenance treatment in
this population. This presentation will trace the historical roots of the conflict, the relationship to stigma, and the scientific data supporting the positions.
Where available, patient selection data will be described.
